Aug 19 (Reuters) - Coloplast A/S COLOb.CO:
OUTLOOK FY ORGANIC GROWTH 7%
Q3 PRETAX PROFIT DKK 1,342 MILLION
Q3 EBIT MARGIN 26%
Q3 ADJUSTED EBIT DKK 1,915 MILLION
Q3 NET INCOME DKK 805 MILLION
Q3 REVENUE DKK 6,958 MILLION
Q3 EBIT DKK 1,832 MILLION
OUR Q3 PERFORMANCE WAS DRIVEN BY BROAD-BASED GROWTH ACROSS OUR CHRONIC CARE BUSINESSES, OFFSETTING CHALLENGES IN CHINA
FY 2024/25 GUIDANCE IS UNCHANGED WITH ORGANIC GROWTH OF AROUND 7% AND AN EBIT MARGIN BEFORE SPECIAL ITEMS OF 27-28%
Source text: ID:nGNE1CC9k5
Further company coverage: COLOb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))